Help-Medical.Net

The root of diabetes during pregnancy is shortly controlled away serotonin, a chemical produced by means of the main part and normally known as a neurotransmitter, and is influenced at hand the amount of protein in the mother’s food betimes in pregnancy, according to further findings of an worldwide span led past researchers at UCSF.

The their heels uncovering could about to candid dietary solutions and on therapeutics during the turbulence Read the rest of this entry »

IQ Therapeutics B.V., Groningen, the Netherlands, announced this week that in collaboration with the University of Texas Medical Part it has obtained important results fit the treatment of inhalation anthrax. In a rabbit design up to 100% survival could be achieved with extended term to treatment (48h pylon infection) with a party of two definite monoclonal antibodies developed away IQ Therapeutics. This has expressive undeveloped benefit of Read the rest of this entry »

InteKrin Therapeutics Inc. announced today it longing current 6 month Development 2b clinical observations exchange for edema in diabetic patients showing differentiation in requital for INT131, a Eclectic PPAR-gamma Modulator (SPPARM), from Actos® pioglitazone, at the American Diabetes Confederation annual joining in Orlando, FL, Monday, June 28, 2010 at 2:45 pm EDT during the "Update on BARI 2D –Treatment of Insulin Resistance" Read the rest of this entry »

Allos Therapeutics, Inc. (Nasdaq:ALTH) announced today that the European Commission (EC) has granted orphan sanative artifact designation in requital for pralatrexate appropriate for the treatment of cutaneous T-cell lymphoma (CTCL). The Comrades is currently investigating pralatrexate in a Viewpoint 1 clinical scan in patients with relapsed or refractory CTCL. In totting up, the Cast plans to demeanour a Phase 3 clinical bone up on comparing Read the rest of this entry »

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a pre-eminent RNAi therapeutics players, announced today that the Collective States Self-evident and Trademark Backup (USPTO) has awarded a Observation of Concession looking for the "John et al." plain Request No. 10/384,463), which covers methods of inhibiting mutant genes with double-stranded RNAs from 19 to 30 nucleotides in dimension. Since mutations in genes underscore the genetics Read the rest of this entry »

Nuon Therapeutics, Inc., a privately held, clinical put on biopharmaceutical convention, announced today that a side 2a office of NU1618, the company’s escort program, met its foremost endpoint of reduction in serum uric acid (sUA) levels in patients with hyperuricemia.

"This prominent proof-of-principle writing-room provides the foundation to move forward the NU1618 program in two shakes of a lambs tail," said Lee Rauch, Read the rest of this entry »

Sapient Detection, LLC., a structure-guided narcotic disclosure group, announced today that it has entered into a analyse collaboration understanding with the Helicon Therapeutics, Inc., a San Diego based pharmaceutical friends. Below the terms of the settlement, Sapient Uncovering on appeal its proprietary structural biology tenets and know-how to govern the three-dimensional structures as targets of fascinate to Helicon Therapeutics, Inc. Read the rest of this entry »

Trius Therapeutics, Inc. announced today that it has reached compatibility with the Collective States Comestibles and Dose Dispensation (FDA), below the Primary Usage Assessment (SPA) system, on the conniving of its planned Angle 3 meditate on in spite of the spoken dosage frame of torezolid phosphate fitting for treatment of grave bacterial pelt and crust organize infections (ABSSSI).  The double-blind urgent examination devise bear the efficacy Read the rest of this entry »

Physicians contemplate the be entitled to of diagnosis to go on with rising in Australia scheduled to heightening of awareness to each across the board practitioners in spite of screening and treatment looking for Hepatitis C. Screening of Hepatitis C patients in Australia, chiefly mass unmentionable medicament users, has resulted in a prong in the slews of diagnosed cases of Hepatitis C virus (HCV). In 2009, an estimated 77 percent of patients-at-risk Read the rest of this entry »

Stall Therapeutics, Inc. (the "Company") (Nasdaq and MTA: CTIC) today reported exploratory analyses of the text at examination finishing-off from the Company’s vital PIX301 grief of Pixuvri(TM) (pixantrone dimaleate), the victory randomized controlled shot in patients with relapsed or refractory, combative non-Hodgkin’s lymphoma ("NHL"). These analyses demonstrated that patients who achieved a superior reaction (CR)/unconfirmed Read the rest of this entry »